BioCardia Receives Formal Nasdaq Delisting Non-Compliance Notice

summarizeSummary

BioCardia received a formal Nasdaq notice for failing to meet minimum stockholders' equity, intensifying delisting risk for the cash-strapped company.

check_boxKey Events

• Nasdaq Non-Compliance Notice

  BioCardia received a formal notice from Nasdaq on April 10, 2026, for non-compliance with the minimum stockholders' equity requirement of $2.5 million, reporting only $895,000 as of December 31, 2025.

• Delisting Risk Intensified

  This notice formalizes the delisting risk previously highlighted in the company's recent 10-K, which also indicated a cash runway only until May 2026.

• Compliance Plan Required

  The company has until May 25, 2026, to submit a plan to regain compliance, with a potential extension of up to 180 days if accepted.

auto_awesomeAnalysis

This 8-K confirms BioCardia's receipt of a formal notice from Nasdaq regarding non-compliance with the minimum stockholders' equity requirement. This event was anticipated by the company's recent 10-K, which highlighted severe liquidity issues and delisting risk. The notice puts additional pressure on the company, which has a cash runway only until May 2026. While the company intends to submit a compliance plan, the formal notice underscores the precarious financial position and the significant risk of eventual delisting, which could severely impact investor confidence and access to capital.